Gateway Wealth Partners LLC Has $46,000 Position in Medical Properties Trust, Inc. (NYSE:MPW)

Gateway Wealth Partners LLC lessened its position in Medical Properties Trust, Inc. (NYSE:MPW) by 44.9% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,559 shares of the real estate investment trust’s stock after selling 8,607 shares during the period. Gateway Wealth Partners LLC’s holdings in Medical Properties Trust were worth $46,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Versant Capital Management Inc increased its stake in shares of Medical Properties Trust by 435.0% in the second quarter. Versant Capital Management Inc now owns 7,972 shares of the real estate investment trust’s stock valued at $34,000 after buying an additional 6,482 shares during the period. Iron Horse Wealth Management LLC increased its stake in shares of Medical Properties Trust by 166.7% in the second quarter. Iron Horse Wealth Management LLC now owns 8,000 shares of the real estate investment trust’s stock valued at $34,000 after buying an additional 5,000 shares during the period. Future Financial Wealth Managment LLC acquired a new stake in shares of Medical Properties Trust in the first quarter valued at about $38,000. Fidelis Capital Partners LLC acquired a new stake in shares of Medical Properties Trust in the first quarter valued at about $43,000. Finally, Gateway Investment Advisers LLC acquired a new stake in shares of Medical Properties Trust in the second quarter valued at about $45,000. Institutional investors and hedge funds own 71.79% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on MPW. Truist Financial increased their price target on Medical Properties Trust from $5.00 to $6.00 and gave the company a “hold” rating in a research note on Friday, September 13th. Colliers Securities upgraded Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 target price on the stock in a report on Friday, September 13th. BNP Paribas downgraded Medical Properties Trust from an “outperform” rating to a “neutral” rating and decreased their price target for the company from $6.00 to $4.00 in a research report on Tuesday, July 2nd. Finally, Wolfe Research raised Medical Properties Trust to a “hold” rating in a research report on Monday, September 23rd. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, Medical Properties Trust has a consensus rating of “Hold” and a consensus target price of $5.22.

Medical Properties Trust Stock Performance

NYSE:MPW opened at $5.86 on Tuesday. The company has a debt-to-equity ratio of 1.51, a current ratio of 2.93 and a quick ratio of 2.93. The business has a fifty day simple moving average of $5.04 and a two-hundred day simple moving average of $4.80. Medical Properties Trust, Inc. has a 1 year low of $2.92 and a 1 year high of $6.55. The company has a market capitalization of $3.51 billion, a P/E ratio of -2.64, a P/E/G ratio of 0.84 and a beta of 1.28.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.75). The firm had revenue of $266.60 million during the quarter, compared to the consensus estimate of $259.53 million. The business’s quarterly revenue was down 21.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.48 EPS. On average, analysts expect that Medical Properties Trust, Inc. will post 0.87 earnings per share for the current year.

Medical Properties Trust Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 10th. Stockholders of record on Monday, September 9th will be given a $0.08 dividend. The ex-dividend date is Monday, September 9th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 5.47%. Medical Properties Trust’s dividend payout ratio (DPR) is currently -14.41%.

Insider Activity at Medical Properties Trust

In other Medical Properties Trust news, Director C Reynolds Thompson III sold 20,530 shares of the stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total value of $89,921.40. Following the sale, the director now directly owns 54,637 shares in the company, valued at approximately $239,310.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Elizabeth N. Pitman sold 10,025 shares of the business’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $4.98, for a total transaction of $49,924.50. Following the completion of the transaction, the director now directly owns 68,653 shares in the company, valued at $341,891.94. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director C Reynolds Thompson III sold 20,530 shares of the company’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total value of $89,921.40. Following the completion of the transaction, the director now owns 54,637 shares in the company, valued at $239,310.06. The disclosure for this sale can be found here. 1.53% of the stock is owned by corporate insiders.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.